Evaluation Of Intramuscular Sodium Nitroprusside Injection To Improve Oxygenation In White-Tailed Deer (Odocoileus Virginianus) Anesthetized With Medetomidine-Alfaxalone-Azaperone

Objective In ungulates, alpha(2)-adrenergic agonists can decrease oxygenation possibly through alteration of pulmonary perfusion. Sodium nitroprusside can decrease pulmonary vascular resistance (PVR) and increase cardiac output ((Q) over dot(t)) through vasodilation. The objective was to determine if sodium nitroprusside would improve pulmonary perfusion and attenuate the increased alveolar-arterial (A-a) gradient resulting from medetomidine-azaperone-alfaxalone (MAA) administration.Study design Prospective, randomized, crossover study with a 2 week rest period.Animals A group of eight adult female captive white-tailed deer (Odocoileus virginianus).Methods Deer were administered MAA intramuscularly (IM), and auricular artery and pulmonary artery balloon catheters were placed. Deer spontaneously breathed air. Saline or sodium nitroprusside (0.07 mg kg(-1)) were administered IM 40 minutes after MAA injection. Heart rate (HR), mean arterial pressure (MAP), mean pulmonary arterial pressure (MPAP), pulmonary artery . occlusion pressure (PAOP), right atrial pressure (RAP), (Q) over dot(t), arterial pH, PaCO2 and PaO2 were obtained immediately before nitroprusside injection (baseline) and 5, 10 and 15 minutes afterwards. Mixed venous blood samples were obtained at baseline and at 5 minutes. Systemic vascular resistance (SVR), PVR, intrapulmonary shunt fraction ((Q) over dot(s)/(Q) over dot(t)), A-a gradient, oxygen delivery (DO2) and oxygen extraction ratio (O2ER) were calculated. Statistical analysis was performed with repeated measures analysis of variance with correction factors. A p value < 0.05 was considered significant. performed with repeated measures analysis of variance with correction factors. A p value < 0.05 was considered significant.Results With nitroprusside, MAP, MPAP, PAOP, RAP, SVR and O2ER significantly decreased and HR, (Q) over dot(t) and DO2 increased compared with baseline and between treatments. There was a significant decrease in PVR and A-a gradient and increase in PaO2 compared with baseline and saline treatment. Changes were not sustained.Conclusions and clinical relevance Nitroprusside temporarily changed hemodynamic variables, increased PaO2 and decreased A-a gradient. Nitroprusside possibly led to better pulmonary perfusion of ventilated alveoli. However, IM nitroprusside at this dose is not recommended because of severe systemic hypotension and short action.